167 related articles for article (PubMed ID: 34333962)
1. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
Lazaryan A; Dolan M; Zhang MJ; Wang HL; Kharfan-Dabaja MA; Marks DI; Bejanyan N; Copelan E; Majhail NS; Waller EK; Chao N; Prestidge T; Nishihori T; Kebriaei P; Inamoto Y; Hamilton B; Hashmi SK; Kamble RT; Bacher U; Hildebrandt GC; Stiff PJ; McGuirk J; Aldoss I; Beitinjaneh AM; Muffly L; Vij R; Olsson RF; Byrne M; Schultz KR; Aljurf M; Seftel M; Savoie ML; Savani BN; Verdonck LF; Cairo MS; Hossain N; Bhatt VR; Frangoul HA; Abdel-Azim H; Al Malki M; Munker R; Rizzieri D; Khera N; Nakamura R; Ringdén O; Van der Poel M; Murthy HS; Liu H; Mori S; De Oliveira S; Bolaños-Meade J; Elsawy M; Barba P; Nathan S; George B; Pawarode A; Grunwald M; Agrawal V; Wang Y; Assal A; Caro PC; Kuwatsuka Y; Seo S; Ustun C; Politikos I; Lazarus HM; Saber W; Sandmaier BM; De Lima M; Litzow M; Bachanova V; Weisdorf D
Haematologica; 2021 Aug; 106(8):2295-2296. PubMed ID: 34333962
[No Abstract] [Full Text] [Related]
2. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
Lazaryan A; Dolan M; Zhang MJ; Wang HL; Kharfan-Dabaja MA; Marks DI; Bejanyan N; Copelan E; Majhail NS; Waller EK; Chao N; Prestidge T; Nishihori T; Kebriaei P; Inamoto Y; Hamilton B; Hashmi SK; Kamble RT; Bacher U; Hildebrandt GC; Stiff PJ; McGuirk J; Aldoss I; Beitinjaneh AM; Muffly L; Vij R; Olsson RF; Byrne M; Schultz KR; Aljurf M; Seftel M; Savoie ML; Savani BN; Verdonck LF; Cairo MS; Hossain N; Bhatt VR; Frangoul HA; Abdel-Azim H; Malki MA; Munker R; Rizzieri D; Khera N; Nakamura R; Ringdén O; van der Poel M; Murthy HS; Liu H; Mori S; De Oliveira S; Bolaños-Meade J; Elsawy M; Barba P; Nathan S; George B; Pawarode A; Grunwald M; Agrawal V; Wang Y; Assal A; Caro PC; Kuwatsuka Y; Seo S; Ustun C; Politikos I; Lazarus HM; Saber W; Sandmaier BM; De Lima M; Litzow M; Bachanova V; Weisdorf D;
Haematologica; 2020 May; 105(5):1329-1338. PubMed ID: 31558669
[TBL] [Abstract][Full Text] [Related]
3. Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Aldoss I; Stiller T; Cao TM; Palmer JM; Thomas SH; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1326-9. PubMed ID: 25842050
[TBL] [Abstract][Full Text] [Related]
4. Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era.
Akahoshi Y; Mizuta S; Shimizu H; Uchida N; Fukuda T; Kanamori H; Onizuka M; Ozawa Y; Ohashi K; Ohta S; Eto T; Tanaka J; Atsuta Y; Kako S;
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2009-2016. PubMed ID: 29908230
[TBL] [Abstract][Full Text] [Related]
5. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
Champlin RE; Schmitz N; Horowitz MM; Chapuis B; Chopra R; Cornelissen JJ; Gale RP; Goldman JM; Loberiza FR; Hertenstein B; Klein JP; Montserrat E; Zhang MJ; Ringdén O; Tomany SC; Rowlings PA; Van Hoef ME; Gratwohl A
Blood; 2000 Jun; 95(12):3702-9. PubMed ID: 10845900
[TBL] [Abstract][Full Text] [Related]
6. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Czyz A; Ottmann O; Baron F; Brissot E; Ciceri F; Cornelissen JJ; Esteve J; Gorin NC; Savani B; Schmid C; Mohty M; Nagler A
Cancer; 2016 Oct; 122(19):2941-51. PubMed ID: 27309127
[TBL] [Abstract][Full Text] [Related]
7. A post-stem cell transplant risk score for Philadelphia-negative acute lymphoblastic leukemia.
Niederwieser D
Haematologica; 2020 May; 105(5):1177-1179. PubMed ID: 32358079
[No Abstract] [Full Text] [Related]
8. Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia.
Shimizu H; Yokohama A; Ishizaki T; Hatsumi N; Takada S; Saitoh T; Sakura T; Handa H
Leuk Res; 2021 Apr; 103():106535. PubMed ID: 33611095
[TBL] [Abstract][Full Text] [Related]
9. Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Giebel S; Boumendil A; Labopin M; Seesaghur A; Baron F; Ciceri F; Esteve J; Gorin NC; Savani B; Schmid C; Wetten S; Mohty M; Nagler A
Ann Hematol; 2019 Oct; 98(10):2389-2398. PubMed ID: 31392462
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612).
Slovak ML; Kopecky KJ; Wolman SR; Henslee-Downey JP; Appelbaum FR; Forman SJ; Blume KG
Leuk Res; 1995 Jun; 19(6):381-8. PubMed ID: 7596150
[TBL] [Abstract][Full Text] [Related]
12. Ph-like gene alterations and complex chromosomal abnormalities are frequent in patients with acute lymphoblastic leukemia experiencing relapse after allogeneic hematopoietic cell transplantation.
Tracy SI; Cao Q; Bachan B; Meredith M; Oseth L; Weisdorf D; Brunstein C; Hirsch B; Bachanova V
Eur J Haematol; 2022 Oct; 109(4):406-408. PubMed ID: 35700331
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis.
Shimizu H; Saitoh T; Machida S; Kako S; Doki N; Mori T; Sakura T; Kanda Y; Kanamori H; Miyawaki S; Okamoto S;
Eur J Haematol; 2015 Nov; 95(5):455-60. PubMed ID: 25605541
[TBL] [Abstract][Full Text] [Related]
14. Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.
Mo XD; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Int J Cancer; 2015 Apr; 136(7):1697-707. PubMed ID: 25138425
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia.
Chang J; Douer D; Aldoss I; Vahdani G; Jeong AR; Ghaznavi Z; Zhang S; Yaghmour G; Lee KJ; Weissman A; Akhtari M
Cancer Med; 2019 Jun; 8(6):2832-2839. PubMed ID: 31016870
[TBL] [Abstract][Full Text] [Related]
16. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Aldoss I; Tsai NC; Slovak ML; Palmer J; Alvarnas J; Marcucci G; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1212-1217. PubMed ID: 27044907
[TBL] [Abstract][Full Text] [Related]
18. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
[TBL] [Abstract][Full Text] [Related]
19. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
[TBL] [Abstract][Full Text] [Related]
20. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
